title: Mechanism of the antialcohol effect of gamma-hydroxybutyric acid.
abstract: Treatment with gamma-hydroxybutyric acid has been reported to effectively decrease alcohol craving and consumption as well as alcohol withdrawal symptoms in alcoholics. We describe the results of animal studies demonstrating the ability of gamma-hydroxybutyric acid to reduce (1) the severity of ethanol withdrawal signs in rats rendered physically dependent on ethanol and (2) voluntary ethanol intake in selectively bred Sardinian alcohol-preferring rats. Furthermore, we review experimental data suggesting that gamma-hydroxybutyric acid and ethanol have several pharmacological effects in common. Relevant similarities are: (1) stimulation of firing rate of dopaminergic neurons and dopamine release in specific rat brain areas; (2) development of cross-tolerance to the motor-impairing effects after repeated administration in rats; 3) abuse potential, as indicated by self-administration of pharmacologically relevant doses of gamma-hydroxybutyric acid in rats and mice; (4) induction of anxiolytic effects in rats; and (5) induction of similar discriminative stimulus effects, as evidenced by symmetrical generalization in a drug discrimination study in rats. These lines of evidence are discussed in relation to gamma-hydroxybutyric acid exerting its antialcohol effects by a substitution mechanism.
authors.affiliation: Bernard B. Brodie Department of Neuroscience, University of Cagliari, Cagliari, Italy.
authors.forename: G L
authors.initials: GL
authors.lastname: Gessa
authors.forename: R
authors.initials: R
authors.lastname: Agabio
authors.forename: M A
authors.initials: MA
authors.lastname: Carai
authors.forename: C
authors.initials: C
authors.lastname: Lobina
authors.forename: M
authors.initials: M
authors.lastname: Pani
authors.forename: R
authors.initials: R
authors.lastname: Reali
authors.forename: G
authors.initials: G
authors.lastname: Colombo
mesh_terms: D000428:Alcohol Drinking; D000437:Alcoholism / Q000188:drug therapy*; D000818:Animals; D004298:Dopamine / Q000502:physiology; D000431:Ethanol / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D006885:Hydroxybutyrates / Q000494:pharmacology* / Q000627:therapeutic use*; D051381:Rats; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D019966:Substance-Related Disorders
chemical_list: D006885:Hydroxybutyrates; C111420:4-hydroxybutyric acid; D000431:Ethanol; D004298:Dopamine